UNSPSC 85812403: Introduction of analgesics, hypnotics, sedatives into mouth and pharynx, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into mouth and pharynx, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0D7NZ

UNSPSC 85812403, a Commodity code describing introduction of analgesics, hypnotics, and sedatives into mouth and pharynx via natural or artificial opening, shows little direct alignment with the recent state and local contract opportunities posted under this code. The nominal scope—oral or pharyngeal drug administration—does not match the actual solicitation activity: the Inland Empire Health Plan virtual urgent care RFI (October 31 response deadline) seeks telehealth-based evaluation and management with prescription authority, DeKalb County's medical services RFP (November 12 deadline) provides no service detail, and the Nevada Health Authority's PACE RFP (December 10 deadline) encompasses comprehensive senior services including pharmacy and behavioral health but not specifically oral/pharyngeal drug introduction. The code mismatch suggests that state and local procurement offices may be tagging health services and behavioral health opportunities broadly under medication-related codes without precision matching to the UNSPSC taxonomy, or that the code itself is being repurposed in practice to cover telehealth and integrated care delivery rather than the discrete clinical procedure it nominally describes.

The issuing bodies include a regional health plan (Inland Empire Health Plan in California), county health systems (DeKalb County, Georgia; Brevard County, Florida; Santa Clara County, California), a state health authority (Nevada), municipal health departments, school districts, special-purpose districts, and behavioral health agencies across multiple states. Geographic spread spans California, Georgia, Nevada, Florida, Kansas, Colorado, Texas, New Jersey, New York, Oregon, Illinois, and the District of Columbia, with no clear concentration in any region. Competitive opportunities are active and range from RFI and RFQ notices to formal RFPs with response dates from September through December 2026. The recent opportunities under this code do not cohere around a single commodity; pursuit of this code requires vendor capability in telehealth infrastructure, integrated care coordination, pharmacy management, or occupational and preventive health services rather than specialized medication administration technique.